XIST and central nervous system cancer: Moreover, the XIST/miR-133a/SOX4 axis also promotes cell growth, metastasis, and the epithelial-mesenchymal transition (EMT), providing a novel target for glioma treatment (Fig. 3D) (Luo et al. 2020).